支付方类型对全关节置换术患者报告结局的影响受基线患者特征调节
本研究基于机构关节登记系统,纳入756例初次择期单侧髋膝关节置换术患者,按保险类型分为医疗补助(273例)、医疗保险(270例)和商业保险(213例)三组。结果显示三组1年净结局改善相当(P > .05),但医疗补助组绝对评分持续较低(P < .01);调整基线差异后,除牛津髋关节评分仍较低(P = .006)外,支付方类型的负面影响消失。
要点
- 医疗补助患者所有患者报告结局的基线平均分显著低于医疗保险或商业保险患者。
- 1年随访时三组净平均结局改善相当(P > .05),但医疗补助组绝对评分持续较低(P < .01)。
- 调整基线差异后,支付方类型的负面影响消失,仅牛津髋关节评分在医疗补助组仍较低(P = .006)。
核心结论
- 使用患者报告结局评估医疗价值时,术前到术后的变化比绝对评分更能反映手术成功,尤其在医疗补助患者中。
- 全关节置换术为所有支付方类型的患者带来相似的净改善,但医疗补助覆盖是任意时间点绝对结局评分较低的预测因素,归因于基线健康负担增加(如抑郁、吸烟和整体健康状况差)。
- 关节置换外科医生在咨询患者时应了解这些因素并在必要时寻求优化。
- 利益相关者在构建基于价值的支付模型时应考虑这些发现。
- 需要进一步研究以更好地理解导致医疗补助受益人健康差异患病率更高的障碍以及如何有效解决。
研究设计与样本
- 查询机构关节登记系统,纳入接受初次、择期、单侧髋和膝关节置换术的患者。
- 根据手术时保险类型将患者分为三组:医疗补助、医疗保险或商业保险。
- 评估结局为患者报告结局的净变化以及6个月和1年时的绝对评分。
- 评估六种最常用的患者报告结局:Short Form-12躯体和心理组分、Western Ontario and McMaster Universities Osteoarthritis Index、Single Assessment Numerical Evaluation、University of Californian Los Angeles activity level rating和Oxford Hip Score。
- 使用方差分析和协方差分析。
主要发现
- 共评估756例手术(医疗补助273例,医疗保险270例,商业保险213例)。
- 医疗补助患者所有患者报告结局的平均基线评分显著低于医疗保险或商业保险患者。
- 医疗补助患者更可能吸烟、独居、教育水平较低、为非裔美国人以及以非原发性骨关节炎为全关节置换术指征。
- 1年随访时,三种支付方类型的净平均结局改善相当(P > .05),但医疗补助患者评分持续较低而医疗保险和商业保险患者评分持续较高(P < .01)。
- 调整医疗补助患者所有基线差异后,支付方类型的负面影响消失,仅牛津髋关节评分在医疗补助组仍较低(P = .006)。
关键数值与推荐
- 医疗补助组273例,医疗保险组270例,商业保险组213例。
- 1年净平均结局改善在三组间相当(P > .05)。
- 1年绝对评分医疗补助组较低而医疗保险和商业保险组较高(P < .01)。
- 调整基线差异后,牛津髋关节评分在医疗补助组仍较低(P = .006)。
临床怎么用
- 关节置换外科医生在咨询患者时应了解这些因素并在必要时寻求优化。
- 利益相关者在构建基于价值的支付模型时应考虑这些发现。
局限性
- 需要进一步研究以更好地理解导致医疗补助受益人健康差异患病率更高的障碍以及如何有效解决。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-reported outcomes (PROs) are gaining an important role in the assessment of quality of care. There are currently limited data on the effect of payer type on PROs in total joint arthroplasty (TJA). This study compared both disease-specific and general health PROs among patients stratified according to their payer type. METHODS: Our institutional joint registry was queried for patients who underwent primary, elective, and unilateral hip and knee arthroplasty. Patients were divided according to their insurance type at the time of surgery into 3 groups: Medicaid, Medicare, or commercial. The outcomes assessed were the net changes in PROs as well as absolute scores at 6 months and 1 year. Six of the most commonly used PROs were assessed: Short Form-12 physical and mental components, Western Ontario and McMaster Universities Osteoarthritis Index, Single Assessment Numerical Evaluation, University of Californian Los Angeles activity level rating, and Oxford Hip Score. Analysis of variance and covariance were used. RESULTS: We evaluated 756 procedures (273 Medicaid, 270 Medicare, and 213 commercial insurance). Medicaid patients had significantly lower mean baseline scores across all PROs compared to either Medicare or commercial insurance patients. Medicaid patients were also more likely to be smokers, live alone, have lower educational level, African-American, and have nonprimary osteoarthritis as the indication for TJA. At 1-year follow-up, the net mean outcome gains were comparable among the 3 payer types (P > .05), but Medicaid patients continued to score lower while Medicare and commercial insurance patients continued to score higher (P < .01). When adjusting for all baseline differences among Medicaid patients, the negative effects of payer type resolved except for Oxford Hip Score which remained lower in the Medicaid group (P = .006). CONCLUSION: When using PROs to assess the value of care, the preoperative to postoperative changes are a better indicator of surgical success than comparing absolute values, especially in Medicaid patients. While TJA imparts similar net improvements to patients of all payer types, Medicaid coverage is a predictor of lower absolute outcome scores at any given time as result of increased baseline health burden (eg, depression, tobacco smoking, and poor overall well-being). Arthroplasty surgeons should be aware of these factors when counseling patients and seek optimization when necessary. The findings should be taken into account by stakeholders when constructing value-based payment models. Further research is needed to better understand the barriers leading to higher prevalence of increased health disparities among Medicaid beneficiaries and how to effectively address them.
引用
- Halawi MJ, Cote MP, Savoy L, et al. The Effect of Payer Type on Patient-Reported Outcomes in Total Joint Arthroplasty Is Modulated by Baseline Patient Characteristics. J Arthroplasty. 2019. PMID: 30797645. doi:10.1016/j.arth.2019.01.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。